Molecular dynamics simulation results of Bamocaftor (Blue), Ivacaftor (Red) and Galicaftor (Green) with CFTR (Black). ανά Naisarg Patel (21772572)

Θέματα:

Results of the MMPBSA analysis. ανά Naisarg Patel (21772572)

Θέματα:

Results of Post-Simulation protonation analysis. ανά Naisarg Patel (21772572)

Θέματα:

Table 1_Practitioners’ and researchers’ perspectives on treatment needs and service provision for online child sexual abuse.docx ανά Felipa Schmidt (17273704)

Data Sheet 2_Decades of failure to prevent harm to patients—where are we going wrong? A mixed methods study of the perspectives of health services staff across Australia and intern... ανά Mia Bierbaum (5899037)

Data Sheet 3_Decades of failure to prevent harm to patients—where are we going wrong? A mixed methods study of the perspectives of health services staff across Australia and intern... ανά Mia Bierbaum (5899037)

Data Sheet 1_Decades of failure to prevent harm to patients—where are we going wrong? A mixed methods study of the perspectives of health services staff across Australia and intern... ανά Mia Bierbaum (5899037)

Participant characteristics. ανά Zamzam I. A. Ali (21688437)

Θέματα: “…acknowledging potential harms…”

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings. ανά Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. ανά Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. ανά Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. ανά Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. ανά Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. ανά Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. ανά Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. ανά Diana M. Hendrickx (1507435)

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings when using the persistent CMA group as a reference. ανά Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. ανά Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... ανά Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. ανά Diana M. Hendrickx (1507435)